These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7787705)

  • 1. [The sequelae of cytochrome P-450 induction].
    Lukienko PI; Zavodnik LB; Bushma MI
    Eksp Klin Farmakol; 1995; 58(1):68-73. PubMed ID: 7787705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of inducers and PCBs on the cytochrome P450 enzymes in cultured quail hepatocytes.
    Roelandt L; Dubois M; Todaro A; Thome JP; Kremers P
    Ecotoxicol Environ Saf; 1995 Jul; 31(2):158-63. PubMed ID: 8521782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.
    Wilkes GM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):33, 52-6. PubMed ID: 19856586
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
    Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
    IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 7. [The induction of microsomal cytochrome P-450 and its medical consequences].
    Pfeil D; Friedrich J
    Pharmazie; 1985 Apr; 40(4):217-21. PubMed ID: 3892550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-pharmacological aspects of enzyme induction].
    Bartłomowicz B
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ; Lake BG
    Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducers of the cytochrome P-450 superfamily as promoters of carcinogenesis.
    Koblyakov VA
    Biochemistry (Mosc); 1998 Aug; 63(8):885-98. PubMed ID: 9767182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressing the specificity and the potency of cytochrome P-450 inducers toward 7-ethoxyresorufin.
    Paolini M; Forti GC; Bauer C
    Drug Metab Dispos; 1990; 18(5):551. PubMed ID: 1981700
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-associated disease: cytochrome P450 interactions.
    Mann HJ
    Crit Care Clin; 2006 Apr; 22(2):329-45, vii. PubMed ID: 16678003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450: new nomenclature and clinical implications.
    Cupp MJ; Tracy TS
    Am Fam Physician; 1998 Jan; 57(1):107-16. PubMed ID: 9447218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of cytochrome p450-1A in the liver of CBA and CC57BR during long-term multiple induction by o-aminoazotoluene].
    Guliaeva LF; Liakhovich VV; Kaledin VI
    Biull Eksp Biol Med; 2000 Mar; 129(3):280-2. PubMed ID: 10776565
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta.
    Ejiri N; Katayama K; Doi K
    Exp Mol Pathol; 2005 Apr; 78(2):150-5. PubMed ID: 15713442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
    Klekotka PA; Halpert JR
    Drug Metab Dispos; 1995 Dec; 23(12):1434-5. PubMed ID: 8689957
    [No Abstract]   [Full Text] [Related]  

  • 18. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
    Filimonova AA; Ziganshin AU; Ziganshina LE
    Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifabutin autoinduction is caused by involvement of cytochrome P450 and cholinesterase.
    Zhaoxu L; Jingcheng T; Jinnan Z
    Pharmazie; 2008 Feb; 63(2):156-9. PubMed ID: 18380404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.